))
Episode 27: Management of Patients with APOL1 Kidney Disease
Manage episode 516154464 series 3689489
Content provided by KDIGO Communications. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KDIGO Communications or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this second installment of KDIGO’s three-part podcast series on APOL1 kidney disease, host Kirk Campbell, MD (University of Pennsylvania, United States), welcomes Barry Freedman, MD (Wake Forest University School of Medicine, United States) for a practical discussion on patient management.
They examine how APOL1 risk variants influence progression, review current therapeutic approaches, and explore emerging targeted treatments designed to improve care and outcomes for affected individuals.
Learn more and access resources from the KDIGO Controversies Conference on APOL1 Kidney Disease: https://kdigo.org/conferences/apol1-kidney-disease/
This podcast was supported by Vertex Pharmaceuticals.
28 episodes
Share
